Initiated clinical trial with novel nasal spray codenamed APR-AOS2020 in patients with mild COVID-19
Product recently cleared in EU as Class III medical device APR Applied Pharma Research s.a. (APR), a leader in the development of pharmaceutical drug delivery technologies and systems and innovative products derived thereof, today announced the start of a pivotal clinical trial to assess the efficacy of its product temporarily codenamed APR-AOS2020, a Class III […]